Page last updated: 2024-08-24

zanamivir and Respiratory Tract Diseases

zanamivir has been researched along with Respiratory Tract Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ajene, AN; Cole, JA; Cook, SE; Loughlin, JE; Rosenberg, DM; Walker, AM1
Brydak, LB; Gawryluk, D; MachaƂa, M; Wiatr, E1
Macdonald, L1

Other Studies

3 other study(ies) available for zanamivir and Respiratory Tract Diseases

ArticleYear
The effect of zanamivir treatment on influenza complications: a retrospective cohort study.
    Clinical therapeutics, 2002, Volume: 24, Issue:11

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Cardiovascular Diseases; Child; Child, Preschool; Cohort Studies; Female; Guanidines; Humans; Influenza, Human; Insurance Claim Reporting; Male; Middle Aged; Otitis Media; Pyrans; Respiratory Tract Diseases; Retrospective Studies; Risk; Seasons; Sialic Acids; Zanamivir

2002
[Significance of virological diagnostics for the effective treatment of hospitalized patients infected with influenza virus].
    Pneumonologia i alergologia polska, 2006, Volume: 74, Issue:2

    Topics: Adult; Amantadine; Antiviral Agents; Diagnosis, Differential; Fluorescent Antibody Technique; Hospitalization; Humans; Influenza A virus; Influenza, Human; Middle Aged; Oseltamivir; Respiratory Tract Diseases; Reverse Transcriptase Polymerase Chain Reaction; Rimantadine; Treatment Outcome; Zanamivir

2006
New influenza drugs zanamivir (Relenza) and oseltamivir (Tamiflu): unexpected serious reactions.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2000, Oct-03, Volume: 163, Issue:7

    Topics: Acetamides; Acute Kidney Injury; Adult; Adverse Drug Reaction Reporting Systems; Aged; Antiviral Agents; Canada; Child; Enzyme Inhibitors; Female; Guanidines; Humans; Male; Middle Aged; Neuraminidase; Oseltamivir; Pyrans; Respiratory Tract Diseases; Sialic Acids; United States; United States Food and Drug Administration; Zanamivir

2000